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Human la antigens are important in the effective collaboration between
immunocompetent cells in the generation of immune responses . The human la
antigens are encoded within the HLA complex and are borne on molecules
composed of two noncovalently associated glycoproteins of ^-34,000 daltons (a
chains) and ^"28,000 daltons (a chains) . Three types ofhuman la molecules have
been identified and biochemically characterized : DR, DS, and SB . DR molecules
display N-terminal amino acid sequence homology to murine I-E molecules (1-
3) . Recent evidence indicates that DR homozygous cells express a single DR a
chain which associates with either of two distinct DR a chains toform two dimeric
DR molecules (3) . SB molecules appear to be structurally different from the
corresponding DR molecules, although SB a chains, like DR a chains, appear to
be homologous to murine I-E a chains (4) . DS (or DC) molecules display N-
terminal amino acid sequence homology to murine I-A molecules (2, 5) . Previous
studies indicate that HLA-DR homozygous cells express a single DS molecule (2,
5) . The data presented here indicate that an HLA-DR5 homozygous cell line
expresses two structurally distinct DS (I-A-like) molecules .
Materials and Methods
BriefDefinitive Report
Cells . The B lymphoblastoid cell line Swei, HLA-A29, A29 ; B40, B40 ; DR5, DR5 ;
MB3 ; MT2, MT4, was obtained from Dr . John Hansen (Fred Hutchinson Cancer Research
Center, Seattle, WA) (6) .
Preparatio?i ofRadiolabeled Antigens.
￿
la antigens were radiolabeled with [s5S]methionine
(700-1,300 Ci/mM, Amersham Corp ., Arlington Heights, IL) and [sH]leucine (130-190
Ci/mM, Amersham Corp .) for two-dimensional (2-D) gel studies or with [sH]leucine for
peptide mapping and immunoprecipitated as previously described (7) .
Antisera.
￿
MGH87B, an anti-MT2 alloserum, and MGH88B, an anti-MT4 serum, were
kindly provided by Dr . Tom Fuller (Massachusetts General Hospital, Boston, MA) (7) .
Rb03 is a rabbit antiserum that detects human la molecules homologous to murine I-A
molecules (2) . Moreover, Rb03 isolated no DR molecules from multiple cell lines in
previous 2-D gel studies (2, 8) .
Two-dimensional (2-D) Gel Electrophoresis. 2-D gel electrophoresis was performed ac-
cording to the method of O'Farrell (9) with modifications as previously described (7) .
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Peptide Mapping by HPLC .
￿
a and a chains of la molecules were isolated by preparative
SDS-1 1%PAGE and the [sH]leucine-labeled tryptic peptides were prepared andseparated
by high pressure liquid chromatography as previously described (10) .
Results
An antigen preparation of the Swei cell line labeled with both [35S]methionine
and [3H]leucine was immunoprecipitated directly with sera MGH87B, MGH88B,
and Rb03 ; the precipitated material was analyzed by 2-D gels . The a and 0 chain
portions of these gels and a schematic diagram of each a and a chain spot pattern
are shown in Fig . 1 . The a chain portions will be discussed first . The a chain
pattern of MGH87B consists of a heterogeneous set of 10 spots . We have
previously shown that this pattern is produced by at least three structurally
distinct /3 chains referred to as ,Q,, 02, and ,Q3 (11) . The a chain pattern of
MGH88B (third panel) consists primarily of01 as we have previously shown (11) .
In addition, the three spots of 02 are very faintly visible on this MGH88B gel .
FIGURE 1.
￿
Fluorographs of 2-D gels of la molecules precipitated from a radiolabeled antigen
preparation of the DR5 homozygous cell line, Swei, by the antisera listed at the left. The first
three panels show material isolated by direct precipitation with MGH87B, Rb03, and
MGH88B, respectively . The three lower panels show sequential immunoprecipitation experi-
ments in which an aliquot of the radiolabeled antigen preparation was first depleted of
MGH88B-reactive material and then divided into three equal aliquots before immunoprecip-
itation with Rb03 (88B/Rb03), MGH87B (88B/87B), and MGH88B (88B/88B), respectively .
Schematic representatives of the spots in each a or ,Q chainR gel are shown to the right of each
gel . In the 0chain schematics, /3 1 is shown as stippled spots, N2 as open spots, as as closed spots,
and0 .i as hatched spots . The three dark spots with <25,000 mol wt at the acidic end of the ,Q
chain gels are invariant and are not related to the fl chains . The acidic end of each a and R
chain gel is the right . The portions of the a and 0 chain gels shown here correspond to pH
5.0-6.0 and pH 6.0-7 .4, respectively .1376
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The # chain pattern of Rb03 (second panel) consists of a heterogeneous set of
11 spots . Four of these spots are identical to ,#, isolated by MGH87B and
MGH88B, as shown here, and by other alloantisera (7, 11) . However, the other
seven spots do not correspond to any of the spots of 02 or 03 and, therefore,
represent a fourth structurally distinct la ,0 chain (N4) on this DR5 homozygous
cell line .
Sequential immunoprecipitation experiments were also performed on the same
antigen preparation to more clearly define the la molecules expressed by this
DR5 homozygous cell line . In these studies, an aliquot of the antigen preparation
was depleted of MGH88B-reactive material and was then divided into three
equal aliquots that were immunoprecipitated with MGH88B, Rb03, and
MGH87B, respectively . Immunoprecipitation of the antigen preparation with
MGH88B after initial removal of MGH88B-reactive material (88B/88B, bottom
panel) isolates no la molecules . This result shows that all of the MGH88B-
reactive material has been removed in the initial precipitation . Immunoprecipi-
tation of the MGH88B-depleted antigen preparation with Rb03 (88B/Rb03,
fourth panel) isolates a # chain pattern of seven spots which corresponds to N4
isolated by Rb03 in the second panel . In comparison with the direct Rb03
precipitate in the second panel, pretreatment with MGH88B in the sequential
has removed the a, chain . This result shows that #4 is a distinct entity that can
be separated from #, . Confirmation that ,#, and N4 were distinct polypeptides was
obtained by comparative tryptic peptide mapping (not shown) . Immunoprecipi-
tation of the MGH88B-depleted antigen preparation with MGH87B (88B/87B)
isolates primarily the /32 and #a chains without a, or /34. Based on the previously
described specificity of Rb03, these data strongly suggest that this cell line
expresses two DS a chains (#, and N4) and, therefore, two DS molecules .
Turning to the a chain portions of the gels (Fig. 1), the a chain pattern of
MGH87B consists ofa heterogeneous pattern of multiple spots. We have previ-
ously shown that this pattern consists of at least two structurally distinct la a
chains, a, and a2 (7) . The MGH88B a chain pattern (third panel) consists of a
complex, heterogenous set of spots that correspond to a2 . The Rb03 a chain
pattern is very similar to, although more intense than, the a2 chain isolated by
MGH88B .
The a chain pattern in the 88B/Rb03 sequential experiment is very similar
qualitatively to the a chain patterns in the individual Rb03 and MGH88B gels .
This is as expected ifa single DS a chain can associate with either of the twoDS
(3 chains and if the determinant(s) recognized by MGH88B is located on the a,
chain of the a2-a, molecule . Therefore, pretreatment with MGH88B in the
sequential has removed the a2A molecule and precipitation of the depleted
antigen preparation by Rb03 isolated the a2 -#4 molecule . The 88B/87B a chain
pattern is very similar to the MGH87B a pattern . This is not unexpected because
of the inclusion of the less intense a2 spots within the area of the more intense
a, spots . The 88B/88B panel documents complete removal ofMGH88B-reactive
material in the initial precipitation . Therefore, it appears that the Swei cell line
expresses a single DS a chain (a2) that can be found in association with either of
the two DS # chains .
The 2-D gel data suggest that thea chains of la molecules isolated by MGH88B
and Rb03 are very similar . In order to better define the relationship betweenU
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FIGURE 2.
￿
Comparative trypticpeptidemaps of ['Hlleucine-labeled a chains of la molecules
isolated by Rb03 (dashed line) and MGH88B (solid line).
these two la a chains, they were isolated by preparative SDS-PAGE andanalyzed
by tryptic peptide mapping using high pressure liquid chromatography. The
peptide maps were run separately, but are plotted on the same graph for
comparison (Fig. 2). Seven major leucine-labeled peptides are resolved in each
case and co-elute. These data indicate that the a chains isolated by Rb03 and
MGH88B are identical, and therefore, that a2 is the DS a chain. Thus the 2-D
gel and tryptic peptide mapping data indicate that the DS a chain (a2) can be
found in association with either of two distinct DS (3 chains (#I and ,Q4).
In summary, serum MGH88B (anti-MT4) precipitated primarily the a2-(3I la
molecule . We have previously shown that two anti-MB3 allosera also precipitated
the a2-a1 molecule (7). Serum Rb03 precipitated two la molecules consisting of
a2-0, and a2-#4" Serum MGH87B (anti-MT2) precipitated three la molecules
consisting of aI-/32, a,-,Q3, and a2A. We have previously shown that another anti-
MT2 alloserum isolates the same three molecules (11). The monoclonal antibody
SG157 that is specific for DR (I-E-like) molecules (1, 2) precipitated the a, -02
and al -03 molecules (data not shown) . Therefore this DR5 homozygous cell line
appears to express two distinct DR molecules and two distinct DS molecules.
Discussion
The data presented here document for the first time that an HLA-DR
homozygous cell line expresses at least two structurally distinct DS (I-A-like)
molecules. We have now identified four distinct la molecules from this DR5
homozygous cell line using two-dimensional gel electrophoresis.
Although human la molecules with N-terminal amino acid sequence homology
to murine I-E molecules were identified in 1978 (12), the human equivalents of
murine I-A molecules were not identified until more recently (1). The rabbit
heteroserum Rb03 is specific for human DS (I-A-like) molecules (2). Both the a
and a chains of human la molecules isolated with Rb03 have N-terminal amino
acid sequence homology to murine I-A a and a chains, respectively (2). Bono
and Strominger (5) have also identified a human I-A homologue; the a chains of
la molecules isolated with the monoclonal antibody Genox 3.53 have N-terminal
amino acid sequence homology to murine I-A a chains . However, only one DS
molecule was identified in these studies (1, 2, 5). In comparative 2-D gel studies
of la molecules isolated by alloantisera and Rb03, we have demonstrated that a
DR5 homozygous cell line expresses two DS molecules.
Because our understanding of the complexity of la molecules finds its most1378
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practical application in tissue typing, it is of interest to locate the serologically
defined allodeterminants on the various la molecules that have been identified.
Previous studies indicated that the serologically defined la antigens, DC1, MB 1,
MT1, LB12, and MB3, are borne on DS molecules (2, 5, 13, 14). The location
of the MT3 determinant is variable: on DR4 cells, the MT3 determinant resides
on DS molecules, while on DR7 cells, the MT3 determinant is found on DR
molecules (8). According to the data presented here and previously (14), the
MT4 allodeterminant, as well as the MB3 allodeterminant, resides on DS mole-
cules. However, the MT4 and MB3 allodeterminants reside on only one (a2-0i)
of the two DS molecules identified on this cell line. In addition, the MT2
allodeterminant appears to reside on both DR molecules but on only one DS
molecule. The finding that MT2 resides on multiple la molecules and is,
therefore, a true supertypic determinant is compatible with previous reports of
anti-la antibodies that recognize epitopes on la molecules encoded by different
genetic subregions in both the murine and human systems (1, 15, 16). This,
then, is the first demonstration that a human la allodeterminant resides on both
DR and DS molecules from thesame cell line . Interestingly, the a2-04 DS molecule
was not isolated by any alloantisera that we have tested. These findings emphasize
the heterogeneity that exists at the molecular level within the MT system of
serologically defined la alloantigens (17): the MT 1 and MT4 allodeterminants
reside only on DS molecules; the MT3 allodeterminant resides on either DR
(DR7) or DS (DR4) molecules; the MT2 allodeterminant (as defined by the
reagents used in these studies) resides on both DR and DS molecules from the
same cell line. Therefore, it is unlikely that all of the serologically defined
allospecificities of the MT system are alleles at a single locus.
The methods of molecular biology have recently been able to identify an
increasing number of genes that determine la a anda chains. Auffray et al. (18)
identified a cDNA clone corresponding to a single human I-A-like a chain. This
group has also demonstrated polymorphism of the DS a chain genes (19). Long
et al . (20) reported the identification of a single I-A-like a chain gene and two
I-A-like # chain genes. However, the identification of multiple la genes does not
prove that all of these genes are expressed and are, therefore, of functional
significance in cell-cell interactions. Our findings at the protein level are consist-
ent with the findings at the gene level of Long et al . (20) and indicate that at
least two DS # chain genes are expressed by this DR5 homozygous cell line.
Summary
Previous studies have indicated that HLA-DR homozygous cell lines express
two DR molecules but only a single DS (I-A-like) molecule . This report dem-
onstrates that an HLA-DR5 homozygous cell line expresses at least two distinct
DS molecules. These two DS molecules are formed by the association of a single
DS a chain with either of two DS ,Q chains. Four distinct la molecules have now
been identified from this DR5 homozygous cell line.
Receivedfor publication 31 May 1983 and in revisedform 5July 1983.
References
1. Goyert, S. M., and J. Silver. 1981 . Isolation of I-A subregion-like molecules from
subhuman primates and man. Nature (Lond.). 294:266.KARR ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
1379
2. Goyert, S. M., J. E. Shively, and J. Silver. 1982. Biochemical characterization of a
second family of human la molecules, HLA-DS, equivalent to murine I-A subregion
molecules. J. Exp. ihled. 156:550.
3. Hurley, C. K., G. Nunez, R. Winchester, O . J. Finn, R. Levy, and J. D. Capra. 1982 .
The human HLA-DR antigens are encoded by multiple ,B-chain loci. J. Immunol.
129:2103 .
4. Hurley, C. K., S. Shaw, L. Nadler, S. Schlossman, and J. D. Capra. 1982. Alpha and
beta chains of SB and DR antigens are structurally distinct.J. Exp. Med. 156:1557.
5. Bono, M. R., and J. L. Strominger. 1982. Direct evidence of homology between
human DC-1 antigen and murine I-A molecules. Nature (Lond.). 299 :836.
6. Hansen, J. A ., S. M. Fu, P. Antonelli, M. Kamoun, J. N. Hurley, R. Winchester, B.
Dupont, and H. G. Kunkel. 1979 . B-lymphoid cell lines derived from HLA-D
homozygous donor. Immunogenetics 8 :51 .
7. Karr, R. W., C. C. Kannapell,J . A . Stein, H. M. Gebel, D. L. Mann, R. J. Duquensoy,
T. C. Fuller, G. E. Rodey, and B. D. Schwartz. 1982. Molecular relationships of the
human B cell alloantigens, MT2, MB3, MT4, and DR5. J. Immunol. 128:1809.
8. Goyert, S. M., J. Moriuchi, R. Winchester, and J. Silver. 1983 . Relationships of HLA-
DS molecules to supertypic specificites. Hum. Immunol. In press.
9. O'Farrell, P. H. 1975. High resolution two-dimensional gel electrophoresis of pro-
teins . J. Biol. Chem. 250:4007.
10. Karr, R. W., Y. Hahn, and B. D. Schwartz. 1981 . Structural identity of human
histocompatibility antigen-B27 molecules from patient with ankylosing spondylitis
and normal individuals. J. Clin. Invest. 69:443.
11 . Karr, R. W., C. C. Kannapell,J . A. Stein, T. C. Fuller, R. J. Duquesnoy, G. E. Rodey,
D. L. Mann, H. M. Gebel, and B. D. Schwartz. 1982. Demonstration of a third
structurally distinct human la, beta chain by two dimensional gel electrophoresis. J.
Exp. Med. 156 :652.
12. Allison, J. P., L. E. Walker, W. A. Russell, M. A . Pellegrino, S. Ferrone, R. A.
Reisfeld, J. A. Frelinger, and J. Silver. 1978. Murine and human DR antigens:
homology of amino-terminal sequences. Proc. Nad. Acad. Sci. USA 75:3953.
13. Shackelford, D. A., D. L. Mann, J. J. van Rood, G. B. Ferrara, and J. L. Strominger.
1981 . Human B-cell alloantigens DC 1, MT 1, and LB 12 are identical to each other
but distinct from the HLA-DR antigen. Proc. Natl. Acad. Sci. USA 78:4566 .
14. Giles, R. C., G. Nunez, C. K. Hurley, A. Nunez-Roldan, R. Winchester, R. Stastny,
and J. D. Capra. 1983 . Structural analysis of a human I-A homologue using a
monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157 :1461 .
15. Symington, F. W., and J. Sprent. 1981 . A monoclonal antibody detecting an la
specificity mapping in the I-A or I-E subregion. Immunogenetics. 14:53.
16. Bhattacharya, A., M . E. Dorf, and T. A. Springer. 1981 . A shared alloantigenic
determinant on la antigens encoded by the I-A and I-E subregions: evidence for I
region gene duplication. J. hnmunol. 127:2488 .
17. Park, M. S., P. I . Terasaki, S. Nakata, and D. Aoki. 1980. Supertypic DR groups:
MT1, MT2, and MT3. In Histocompatibility Testing 1980. P. I . Terasaki, editor.
UCLA Tissue Typing Laboratory, Los Angeles. p. 854.
18. Auffray, C., A. J . Korman, M. Roux-Dosseto, R. Bono, and J. L. Strominger. 1982.
cDNA clone for the heavy chain of the human B cell alloantigen DC 1 : strong
sequence homology to the HLA-DR heavy chain. Proc. Nad. Acad. Sci. USA. 79:6337.
19. Auffray, C., A. Ben-Nun, M . Roux-Dossetto, R. N. Germain, J. G. Seidman, and J.
L. Strominger. 1983. Polymorphism and complexity of human DC and murine I-A
alpha chain genes. EMBO (Fur. Mol. Biol. Org.) J. 2:121 .
20. Long, E., J. Gorski, C. Rabourdin-Combe, C . Wake, and B. Mach. 1983 . Molecular
genetics of the immune response region of the human major histocompatibility
complex. Chn. Res. 31 :492A.